Robin Cheiken graduated from Thomas Jefferson University in Philadelphia, Pennsylvania in 1991 with a Bachelor Science Degree in Nursing. Robin began her career in oncology research as a clinical trials nurse at the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center in Washington, DC. In 2000, she accepted the position as the Serious Adverse Events Manager for the Investigational Drug Branch in CTEP/NCI-US, where she managed the team responsible for the collection, analysis, and timely reporting of serious adverse events (SAE’s) to the Food and Drug Administration (FDA) for CTEP monitored clinical investigations.

Martha studied Nursing in Montreal and graduated in 1987. She moved to Toronto in 1988 and has been working at Princess Margaret Hospital for 19 years.  Martha has worked in various areas within the institution; Leukemia in-patient unit, Chemotherapy Daycare Unit, Surgical Out-Patient clinics and for three years assisted with developing the Ambulatory Pump Program.

I started a two-year fellowship program as a Clinical Research Fellow in the Robert and Maggie Bras & Family  New Drug Development Program at Princess Margaret Hospital in November 2007.  My planned date of completion is October 2009. I am currently involved in all aspects of the evaluation and management of patients on early phase clinical trials. In addition, I actively participate in various research activities and am involved in the design and implementation of clinical trial protocols, and clinical, translational and/or laboratory research. 

Dr. Amit Oza is a Senior Staff Physician and Associate Professor of Medicine at Princess Margaret Hospital, University of Toronto. He is Co-Director of the Robert and Maggie Bras and Family Drug Development Program and a Scientist with the Ontario Cancer. He graduated from St. Bartholomew’s Hospital, University of London (UK), in 1983 and completed his internal medicine and medical oncology training in UK. He completed Clinical Research Fellowships at St. Bartholomew’s Hospital/Imperial Cancer Research Fund, London (UK), Princess Margaret Hospital, Toronto and at the Netherlands Cancer Institute, Amsterdam. His postgraduate research thesis was on Molecular Epidemiology of Hodgkin’s Disease. He is a Fellow of the Royal College of Physicians of London and Canada.

Dr. Stephen Welch joined the Robert & Maggie Bras New Drug Development Program as a Clinical Research Fellow in July 2005. He received the Roche Fellowship to pursue further training in cancer clinical trials. Stephen completed his medical oncology residency at the University of Western Ontario, having received undergraduate medicine and internal medicine credentials at the University of Manitoba. In his time at Princess Margaret Hospital, Stephen has been active in design and conduct of early phase clinical trials, with five ongoing protocols to his credit.

Dr. Lillian Siu is a staff physician in the Department of Medical Oncology and Hematology at Princess Margaret Hospital (PMH) since 1998, and is an associate professor at the University of Toronto.  She graduated from the University of Toronto, Faculty of Medicine, in 1991.  After her residency in Medical Oncology at PMH, she completed Drug Development Fellowships at PMH and at the University of Texas Science Center, San Antonio.

Dr. Carol Townsley has been a clinical fellow working in the Robert & Maggie Bras and Family New Drug Development Program at Princess Margaret Hospital for the past 3 years.

Shirley graduated with honours from the nursing program at Georgian College of Arts and Technology in 1992. While working as a Registered Nurse at Princess Margaret Hospital she obtained her certificate in oncology nursing with the Oncology Nursing Society.

Sheila Webster graduated from The University of Toronto Faculty of Nursing in 1986 with a Bachelor Science Degree of Nursing.

Jane Nagai is the Clinical Trial Pharmacist for the Robert and Maggie Bras and Family New Drug Development Program.